CREGS - Results of a large High-Quality Comparative Effectiveness Research Study

Dr. Daniel Sanak presented results from the recently published CREGS study, a large international, real-world investigation evaluating the effectiveness and safety of Cerebrolysin in patients with moderate acute ischemic stroke (AIS). His presentation emphasized the clinical value of adjunctive cerebroprotective therapy in improving functional recovery and extending benefits beyond reperfusion.